Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Finance

L'Oreal takes stakes in Chinese, N.American clinics to understand medical aesthetics market

Published by Global Banking & Finance Review

Posted on February 7, 2025

1 min read

· Last updated: January 26, 2026

Add as preferred source on Google

L'Oreal's investment in clinics highlights its strategy in the medical aesthetics market - Global Banking & Finance Review — This image illustrates L'Oreal's recent investments in clinics across China and North America, showcasing their strategic approach to understanding the medical aesthetics market. The article discusses how these moves aim to enhance L'Oreal's presence in the growing field of nutricosmetics and skin care.

Global Banking & Finance Awards 2026 — Call for Entries

L'Oreal Invests in Clinics to Understand Aesthetics Market

PARIS (Reuters) - L'Oreal has taken stakes in clinics in China and North America in order to observe and understand the medical aesthetics market, L'Oreal CEO Nicolas Hieronimus said in an earnings call on Friday.

The company had announced in August the acquisition of a 10% stake in Swiss skin care firm Galderma.

Hieronimus added that L'Oreal would be entering the nutricosmetics market with a new product and said more would be coming.

(Reporting by Dominique Patton; Editing by Makini Brice and David Evans)

Key Takeaways

L'Oreal invests in clinics in China and North America.
The move aims to understand the medical aesthetics market.
L'Oreal acquired a 10% stake in Galderma.
The company plans to enter the nutricosmetics market.
CEO Nicolas Hieronimus announced these strategic moves.

Frequently Asked Questions

What is the main topic?

The article discusses L'Oreal's investment in clinics to understand the medical aesthetics market and its entry into nutricosmetics.

Why is L'Oreal investing in clinics?

L'Oreal is investing to observe and understand the medical aesthetics market in China and North America.

What is nutricosmetics?

Nutricosmetics refers to products that combine nutrition and cosmetics, aiming to improve beauty from within.

Microsoft will no longer have exclusive access to OpenAI's technology

Nations meet to discuss fossil fuel exit as Iran war drives up prices

Italy calls for EU to treat energy spending like defence in bloc's budget rules

Prada seeks to mend ties with 'Made in India' sandals

Hungary and EU to discuss terms of release for billions in blocked funds

Critical Metals to acquire European Lithium for $835 million

More from Finance

Explore more articles in the Finance category

Wizz Air does not expect to run out of jet fuel, CEO says

Vinted valued at 8 billion euros after EQT-led share sale

Russia's oil and gas tax revenues seen rising in May, but still down year to date

Germany's Merz says Iran is humiliating US as talks stall

UK Consumer Lending: Regulation, Reform, and Rising Confidence

Shell to buy ARC Resources in $16.4 billion deal

Qualcomm surges on report of OpenAI tie-up for AI smartphone processors

Sendly NBFI JSC Awarded Best Money Transfer Provider in Mongolia 2026 by Global Banking & Finance Review®

Tech firm Cint climbs after Triton-backed group announces takeover bid

QIC Digital Hub Recognised as Best Place to Work Qatar 2026 at the 2026 Global Banking & Finance Review Awards®

PRIMA FINANTARE Named Best New SME Finance Company Romania 2026 at the 2026 Global Banking & Finance Review Awards®

Britain's financial regulator consults on changes to IPO research

View All Finance Posts